MedTrace Logo

MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer

NCT03400657 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 484

Last updated 2018-01-17

No results posted yet for this study

Summary

This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer after MDT discussion under real medical practice.

Conditions

  • Multi-disciplinary Treatment

Interventions

PROCEDURE

Multi-disciplinary Treatment

due to suggestion of Multi-disciplinary Treatment ,the patients would be suggested to chemotherapy or surgery.

Sponsors & Collaborators

  • Peking University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2020-01-31
Completion
2020-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03400657 on ClinicalTrials.gov